- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: E2006 5.0 mg
Total 11951 results
-
Eisai Inc.Completed
-
Eisai Inc.Completed
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
Eisai Inc.Eisai LimitedCompletedDiabetic NeuropathyUnited States
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, France, United Kingdom, Italy
-
Regado Biosciences, Inc.CompletedHealthy VolunteerUnited States
-
Santen Inc.CompletedAge-Related Macular DegenerationUnited States
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Novo Nordisk A/SCompleted
-
Eisai Inc.CompletedHealthy SubjectsUnited States
-
Cerevel Therapeutics, LLCRecruitingApathy in DementiaUnited States, Canada
-
Eisai Inc.Completed
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
AblynxCompletedRespiratory Syncytial Virus Lower Respiratory Tract InfectionBelgium, Hungary, Israel, Spain, Estonia, Philippines, Thailand, Bulgaria, Poland, Germany, Chile, Colombia, Croatia, Czechia, Latvia, Malaysia, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Merck Sharp & Dohme LLCCompletedHypertension | Isolated Systolic Hypertension (ISH)
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
-
Eisai Inc.CompletedMetabolism and ExcretionUnited States
-
Eisai Inc.CompletedInsomniaUnited States
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Dysfunction | Female Sexual Arousal Disorder
-
Novartis PharmaceuticalsCompleted
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
ReveraGen BioPharma, Inc.University of Pittsburgh; Cooperative International Neuromuscular Research...CompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
Eisai Inc.Completed
-
Minerva NeurosciencesCompletedMajor Depressive DisorderUnited States, Bulgaria, Finland, Georgia, Moldova, Republic of, Poland, Ukraine
-
MedImmune LLCAstraZenecaTerminatedLupus Erythematosus, SystemicUnited States, Mexico, Peru, South Africa, Canada
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
Eisai Inc.Completed
-
Eisai Inc.Terminated
-
Duke UniversityMedartis AGCompletedPost-traumatic Osteoarthritis, Unspecified Ankle and Foot | Localized, Primary Osteoarthritis of the Ankle and/or FootUnited States
-
Janssen Research & Development, LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Lpath, Inc.CompletedHealthy SubjectsUnited States
-
Eisai Inc.Completed
-
Celtic Pharma Development ServicesCompleted
-
Idorsia Pharmaceuticals Ltd.Completed
-
Taipei Medical UniversityCompleted
-
Clementia Pharmaceuticals Inc.TerminatedExostoses, Multiple HereditaryUnited States, Spain, Canada, Japan, Italy, Portugal, United Kingdom, Turkey, Australia, Belgium, France, Netherlands
-
Merck Sharp & Dohme LLCCompleted
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Eisai Inc.CompletedPartial Onset Seizures | Primary Generalized Tonic-Clonic Seizures | Secondarily Generalized SeizuresUnited States
-
PfizerTerminatedAlzheimer DiseaseUnited States, Colombia, Korea, Republic of, Russian Federation, Japan, Hong Kong, South Africa, Poland, Chile, Romania, Mexico, Argentina, New Zealand
-
Galapagos NVCompleted
-
Lexicon PharmaceuticalsCompletedRheumatoid ArthritisUnited States